Alison Opalko News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CatalYm to Present Positive New Phase 2a Follow-up Data on GDF-15 Neutralizing Antibody Visugromab in Advanced NSCLC, Urothelial, and Hepatocellular Cancer at the 2024 ASCO Annual Meeting

Oral presentation in "Developmental Therapeutics-Immunotherapy" session on Sunday, June 2, 2024, at 11:30 AM CDT CatalYm today announced that positive new follow-up results from its ongoing "GDFATHER"

Mccormick placeUnited statesPhil lhuilierIgnacio melero bermejoCatalym gmbAlison opalkoTrophic communicationsOncology congressAmerican society of clinical oncologyTed human effector cell relocation phaseAmerican societyClinical oncologyAnnual meetingGrowth differentiationPresentation detailsUniversidad de navarra

TOLREMO therapeutics AG: TOLREMO Welcomes Dr Alan Sandler to Scientific Advisory Board

TOLREMO therapeutics AG: TOLREMO Welcomes Dr Alan Sandler to Scientific Advisory Board
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesExperte carsten storkGretchen schweitzerAlan sandlerZwei rohstoff chancenRush medical collegeYale new haven medical centerOregon healthZai labBristol myers squibbRoche groupTrophic communicationsVanderbilt universityGlobal head of developmentIndiana university as assistant professor of medicineProduct development of oncology solid tumors

Topas Therapeutics Appoints Hugo Fry as CEO

Topas Therapeutics Appoints Hugo Fry as CEO
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofAlison opalkoSanofi pasteurErichf greinerUniversity of salfordLondon business schoolImbria pharmaceuticalsBoehringer ingelheim venture fundDuke universityTrophic communicationsIndustrial affairsHugo fryChief executiveExecutive chairmanChief commercial officer

Actym Therapeutics Appoints Thomas Smart as CEO

/PRNewswire/ Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today the appointment of Thomas Smart as Chief Executive.

United statesChris thanosThomas smartSara ortizJulie cherringtonCornell universityTrophic communicationsGenetics instituteUniversity of chicago booth school businessBasilea pharmaceutica ltdMaster of business administrationActym therapeutics incChief executiveAttenuated cancer therapyExecutive chairActym board

Sibylla Biotech Appoints Sonia Poli as Chief Scientific Officer

Sibylla Biotech Appoints Sonia Poli as Chief Scientific Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalAlison opalkoDegraders fidsDimerix bioscienceEli lillyLidia pieriTrophic communicationsSonia poliChief scientific officerFolding interfering degradersChief executive officerLife cycle leaderVice presidentTranslational scienceAddex therapeuticsIndustrial chemistry